Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Middle East Healthcare Co's Revenue for the
three
months ended in Jun. 2026 was ﷼846 Mil. Middle East Healthcare Co's average Accounts Receivable for the
three
months ended in Jun. 2026 was ﷼1,957 Mil.
Hence, Middle East Healthcare Co's Receivables Turnover for the
three
months ended in Jun. 2026 was 0.43.
Middle East Healthcare Co (SAU:4009) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Middle East Healthcare Co Receivables Turnover Related Terms
Middle East Healthcare Co Receivables Turnover Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Middle East Healthcare Co Receivables Turnover Chart
SAU:4009 vs HCA, THC, DVA: Receivables Turnover Comparison
For the Medical Care Facilities subindustry, Middle East Healthcare Co's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Middle East Healthcare Co Receivables Turnover vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Middle East Healthcare Co's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Middle East Healthcare Co's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Middle East Healthcare Co (SAU:4009) has a Receivables Turnover of 0.43 as of Jun. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Middle East Healthcare Co and its competitors. According to the industry distribution chart, Middle East Healthcare Co ranks #639 out of 659 companies in the Healthcare Providers & Services industry, placing it in the top 97%.
Is Middle East Healthcare Co's Receivables Turnover too high?
Middle East Healthcare Co's current Receivables Turnover is 0.43. The Healthcare Providers & Services industry median Receivables Turnover is 7.98. Middle East Healthcare Co's value of 0.43 is 94.6% below this industry median. Based on the distribution chart, Middle East Healthcare Co ranks #639 out of 659 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Middle East Healthcare Co has a GF Score™ of 75/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Middle East Healthcare Co's Receivables Turnover compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Middle East Healthcare Co ranks #639 out of 659 companies for Receivables Turnover. This places Middle East Healthcare Co in the lower half of its industry. The industry median Receivables Turnover is 7.98. Middle East Healthcare Co's value of 0.43 is 94.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Healthcare Providers & Services company?
The median Receivables Turnover among Healthcare Providers & Services companies is 7.98, based on 659 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Middle East Healthcare Co's current Receivables Turnover of 0.43 is 94.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Middle East Healthcare Co and its competitors. For the Healthcare Providers & Services industry, the median Receivables Turnover is 7.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Middle East Healthcare Co's current Receivables Turnover is 0.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Middle East Healthcare Co stock overvalued right now?
Based on GuruFocus' analysis, Middle East Healthcare Co (SAU:4009) is currently considered Possible Value Trap. The stock's GF Value™ is ﷼76.95, compared to a current price of ﷼32.10 — trading 58.3% below its estimated fair value. The current Receivables Turnover is 0.43 and 94.6% below the Healthcare Providers & Services industry median of 7.98. Middle East Healthcare Co's overall GF Score™ is 75/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Middle East Healthcare Co (SAU:4009), the current Receivables Turnover is 0.43 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Middle East Healthcare Co (SAU:4009) Overvalued in 2026?
Based on GuruFocus' analysis, Middle East Healthcare Co stock appears to be undervalued.
The current stock price of ﷼32.10 is trading 58.3% below its estimated GF Value™ of ﷼76.95.
GuruFocus considers Middle East Healthcare Co to be Possible Value Trap.
Key valuation signals for SAU:4009:
Receivables Turnover: 0.43
GF Value™: ﷼76.95 vs. price of ﷼32.10 (58.3% below fair value)
Industry Position: 94.6% below the Healthcare Providers & Services median (#639 of 659)
No single metric tells the full story. See the SAU:4009 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Middle East Healthcare Co is a Saudi Arabia-based company engaged in the business of managing, operating and maintaining hospitals, medical centers, educational centers, rehabilitation centers, physiotherapy, laboratories and radiology centers, pharmacies, construction, and to buy land for the purpose of constructing medical projects and to establish, manage and organize exhibitions for the company. The company's reportable segments are Inpatient Services, Outpatient Services, Pharmacy Sales and Others. The majority of revenue is derived from the Inpatient Services segment.
75GF Score
Get the complete analysis for SAU:4009
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:4009 has been successfully added to your 
